Heparane sulfamidase deficiency

Heparan Sulfamidase Deficiency is a rare, genetic disorder characterized by a deficiency of the enzyme heparan sulfamidase. This enzyme is crucial for the degradation of heparan sulfate, a complex sugar molecule found in various tissues throughout the body including the brain, skin, and connective tissues. The deficiency leads to the accumulation of heparan sulfate in cells, causing progressive damage and a range of clinical symptoms. Heparan Sulfamidase Deficiency is the underlying cause of Sanfilippo Syndrome Type A, one of the four types of Sanfilippo Syndrome, a form of mucopolysaccharidosis (MPS III).

Symptoms and Diagnosis

The symptoms of Heparan Sulfamidase Deficiency typically begin in childhood and may include developmental delay, behavioral problems, sleep disturbances, and physical features such as coarse facial features, stiff joints, and short stature. As the disease progresses, severe neurological symptoms develop, including severe intellectual disability, loss of previously acquired skills (developmental regression), and movement disorders.

Diagnosis is based on clinical evaluation, detection of increased levels of heparan sulfate in urine, and genetic testing confirming mutations in the SGSH gene, which encodes the heparan sulfamidase enzyme. Enzyme activity assays in leukocytes or fibroblasts can also confirm the diagnosis by demonstrating reduced or absent activity of heparan sulfamidase.

Treatment and Management

There is currently no cure for Heparan Sulfamidase Deficiency. Treatment is symptomatic and supportive, focusing on managing symptoms and improving quality of life. This may include physical therapy, occupational therapy, and speech therapy to support developmental skills. Medications may be used to manage behavior problems, sleep disturbances, and seizures. In some cases, surgery may be necessary to address physical abnormalities such as hernias or to insert feeding tubes in patients with severe feeding difficulties.

Research and Future Directions

Research into Heparan Sulfamidase Deficiency is ongoing, with efforts focused on developing gene therapy, enzyme replacement therapy, and substrate reduction therapy as potential treatments. These approaches aim to restore the function of heparan sulfamidase, reduce the accumulation of heparan sulfate, or both, thereby preventing or reversing the progression of the disease.

See Also

• Mucopolysaccharidosis
• Sanfilippo Syndrome
• Genetic Disorders
• Enzyme Replacement Therapy
• Gene Therapy

Heparane sulfamidase deficiency Resources
Latest articles Most recent articles Ongoing trials	Wikipedia